Sam Brusco, Associate Editor02.06.24
icotec has appointed Christoph Eigenmann as its new CEO for the U.S.
Eigenmann has over two decades of medical technology industry, having served in significant roles at Johnson & Johnson. He brings extensive experience in commercial organizations in Europe and the U.S., especially in the spine business, according to icotec.
Eigenmann said, "I am very excited to join icotec Medical. icotec is a clear innovation leader in the spine space, and I am looking forward to leading their US team and to contributing to the company's global success."
![](https://images.rodpub.com/images/299/581_main.jpg)
Carter Lonsberry
Carter Lonsberry, who led icotec U.S. in the first couple years, was named as the U.S. executive chairman of the board.
"I am honored by this promotion and excited to contribute to the company's strategic direction at the executive level,” he commented.
icotec is known for its BlackArmor carbon/PEEK implants and is a leader in the field of high-tech tumors to treat spinal tumors.
Roger Stadler, group CEO of icotec ag, said, "We are thrilled to welcome Christoph Eigenmann as our new U.S. CEO. His leadership and experience are exactly what we need to expand our presence in the US market. Additionally, Carter Lonsberry's promotion to the Executive Board reflects our commitment to internal talent development and strategic leadership."
Last month, the company established a strategic partnership with global healthcare venture capital firm, MVM Partners. The partnership helps icotec to commercialize its BlackArmor Carbon/PEEK products.
Eigenmann has over two decades of medical technology industry, having served in significant roles at Johnson & Johnson. He brings extensive experience in commercial organizations in Europe and the U.S., especially in the spine business, according to icotec.
Eigenmann said, "I am very excited to join icotec Medical. icotec is a clear innovation leader in the spine space, and I am looking forward to leading their US team and to contributing to the company's global success."
![](https://images.rodpub.com/images/299/581_main.jpg)
Carter Lonsberry
"I am honored by this promotion and excited to contribute to the company's strategic direction at the executive level,” he commented.
icotec is known for its BlackArmor carbon/PEEK implants and is a leader in the field of high-tech tumors to treat spinal tumors.
Roger Stadler, group CEO of icotec ag, said, "We are thrilled to welcome Christoph Eigenmann as our new U.S. CEO. His leadership and experience are exactly what we need to expand our presence in the US market. Additionally, Carter Lonsberry's promotion to the Executive Board reflects our commitment to internal talent development and strategic leadership."
Last month, the company established a strategic partnership with global healthcare venture capital firm, MVM Partners. The partnership helps icotec to commercialize its BlackArmor Carbon/PEEK products.